期刊文献+

临产孕妇凝血指标和血小板参数的变化及其临床意义 被引量:8

Changes and clinical significance of coagulation indicators and platelet parameters in labor pregnant women
原文传递
导出
摘要 目的探讨临产孕妇凝血指标和血小板参数的变化及其临床意义。方法对136例临产孕妇(临产组)和40例正常非孕妇女(对照组)的凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)、D-二聚体(D-D)以及血小板计数(PLT)、血小板体积分布宽度(PDW)、平均血小板体积(MPV)进行检测。结果临产组与对照组相比较:PT、APTT、TT时间明显缩短,FIB、D-D、PDW、MPV水平显著增高,差异均有统计学意义(P<0.01);PLT有所降低,但差异无统计学意义(P>0.05)。结论在产前、产中进行凝血指标及血小板参数的监测,对防止产妇血栓形成及弥漫性血管内凝血的发生,确保母婴的身心健康有重要意义。 Objective To investigate the changes and clinical significance of coagulation indicators and platelet parameters in labor pregnant women.Methods The prothrombin time(PT),activated partial thromboplastin time(APTT),thrombin time(TT),the level of fibrinogen(FIB) and D-dimer(DD),and platelet count(PLT),platelet volume distribution width(PDW),mean platelet volume(MPV) in 136 labor pregnant women(labor group) and 40 nomal women(control group) were detected.Results Compared with the control group: PT,APTT,TT in labor group was significantly shorter,FIB,DD,PDW,MPV was significantly higher,and the differences were statistically significant(P0.01);and the PLT was decreased,but there was no significant difference between the two groups(P0.05).Conclusion Detection of coagulation indicators and platelet parameters in prenatal and perinatal period,is important to prevent the occurrence of maternal thrombosis and DIC,and to ensure the physical and mental health of the mother and child.
作者 王秀华
出处 《临床医学》 CAS 2013年第5期31-32,共2页 Clinical Medicine
关键词 临产孕妇 凝血指标 弥漫性血管内凝血 血小板参数 Labor pregnant women Coagulation indicators Disseminated intravascular coagulation Platelet parameters
  • 相关文献

参考文献7

二级参考文献51

  • 1金海山,杜秋.妊高征患者凝血及血小板检测的临床意义[J].现代医药卫生,2004,20(17):1726-1727. 被引量:7
  • 2张春荣.临产孕妇凝血四项指标的变化及临床意义[J].微循环学杂志,2004,14(4):77-77. 被引量:31
  • 3高玲,黄彬,林爱华,钟武平,刘敏,万建新,姜傥,张建平,陈敦金.产科早期弥漫性血管内凝血患者止凝血功能的研究[J].中华检验医学杂志,2006,29(12):1144-1147. 被引量:36
  • 4Gao M, Nakabayashi M, Sakura M, et al. The imbalance of plasminogen activators and inhibitor in prceclampsia [J]. Obstetrics Gynccolo Res, 1996, 22(1): 9-16.
  • 5Rempher K.I, Little J. Assessment of red blood cell and coagulation laboratory data [J]. AACN Clin Issues, 2004, 15(4): 622-637.
  • 6Mello G, Parretti E, Marozio L, et al. Thrombophilia is significant- ly associated with severe preeclampsia: results of a large-scale, case-controlled study [J]. Hypertension, 2005, 46(6): 1270-1274.
  • 7Jaremo P, Lindahl TL, Lennmarken C, et al. The use ofplatelet density and volume measurements to estimate the severity of preeclampsia [J]. Eur J Clin Invest, 2000, 30(12): 1113-1118.
  • 8Naicker S. Nutritional problems associated with end-stage renal disease in the developing world [J]. Artif Organs, 2002, 26(9): 757-759.
  • 9Levi M,De Jonge E,Van Der Poll T.New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology[J].Ann Med,2004,36(1):41-49.
  • 10Toh CH,Downey C.Back to the future:testing in disseminated intravascular coagulation[J].Blood Coagul Fibrinolysis,2005,16(8):535-542.

共引文献89

同被引文献41

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部